Live Breaking News & Updates on Decision software

Stay informed with the latest breaking news from Decision software on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Decision software and stay connected to the pulse of your community

MarketWide - Campaign Management Made Simple

Efficiently manage and automate marketing campaigns with MarketWide, the campaign management and database marketing tool for organizations of all sizes.

Decision-software-inc , Oracle , Tech-times , Decision-software , Customer-data-platforms , Campaign-management , Atabase-marketing-tool ,

Endocrinology Month in Review: May 2023

Each month, our editorial staff compiles a recap of the top news in endocrinology from the past month. Our April 2023 month in review features new FDA approvals, important phase 2 data, and in-depth clinician perspective.

California , United-states , American , Deepak-bhatt , Diana-isaacs , Natalie-bellini , Ascendis-pharma , Zealand-pharma , Metabolic-care-center , Boehringer-ingelheim , National-health , Decision-software

FDA clears new insulin pump for Type 1 Diabetes treatment - Westfair Communications

The U.S. Food and Drug Administration (FDA) has granted clearance to Beta Bionics Inc. for the company’s Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for use by people ages six years and older with type 1 diabetes.

Jeff-shuren , Decision-software , Radiological-health , Drug-administration , Beta-bionics-inc , Beta-bionics , Let-dosing-decision-software , Let-bionic ,

FDA Clears iLet Bionic Pancreas for Patients With Type 1 Diabetes

The FDA has cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for persons 6 years of age and older with type 1 diabetes.

Jeff-shuren , Decision-software , Drug-administration , Radiological-health , Beta-bionics , Let-dosing-decision-software , Let-bionic , Let-bionic-pancreas ,

FDA Grants Clearance to iLet Bionic Pancreas

Announced by the US FDA on May 19, 2023, the clearance of the iLet ACE Pump and the iLet Dosing Decision Software, when combined with a compatible CGM, will form the iLet Bionic Pancreas.

United-states , American , Ed-damiano , Jeff-shuren , Steven-russell , American-diabetes-association , Radiological-health , Decision-software , Drug-administration , Beta-bionics , Let-dosing-decision-software , Let-bionic-pancreas

FDA Clears iLet Bionic Pancreas Insulin Delivery System

The FDA has cleared a next-generation insulin pump and software combination that provides greater automation than current "artificial pancreas" systems.

United-states , American , Royw-beck , Annel-peters , University-of-southern-california , American-diabetes-association , Decision-software , Drug-administration , Keck-school-of-medicine , Beta-bionics , Let-dosing-decision-software

FDA Clears iLet Bionic Pancreas for Patients With Type 1 Diabetes

The FDA has cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for persons 6 years of age and older with type 1 diabetes.

Jeff-shuren , Decision-software , Drug-administration , Radiological-health , Beta-bionics , Let-dosing-decision-software , Let-bionic , Let-bionic-pancreas ,